Tami Mark

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Results

Filter

Filter by Type

Filter by Year

Filter by Focus Area

Search Results

Data Analysis and Reporting

Medicare Part D Plans Have Removed Barriers to Opioid Use Disorder Medications

Buprenorphine prescribing for Medicaid beneficiaries down in 2020

CMS Policy Change Improved Addiction Treatment Access

Prior Authorization for Common Opioid Use Disorder Medications Associated with More Adverse Health Outcomes, Study Finds

RTI Researchers to Present at 2021 Rx Drug Abuse & Heroin Summit

First-of-its-kind research article details substance use disorder prevalence among Medicare beneficiaries and the treatment barriers they face

New Study Finds Patients on High Doses of Opioid Medication Are Being Rapidly Discontinued, Leading to Greater Risk of Emergency Department Visits and Hospitalizations

‘I’m Trying Not to Die Right Now’: Why Opioid-Addicted Patients Are Still Searching for Help

Study: Costs to add substance abuse coverage to Medicare to only increase spending by nominal amount

CMS Health Equity Conference

New study shows nominal cost of adding substance use disorder services to Medicare

New study finds continuing pervasive disparities in access to in-network mental health and substance use disorder treatment

Growth in use of medications to treat opioid use disorders stalled during pandemic, study finds

28% Fewer People Began Addiction Treatment During the COVID-19 Pandemic, New Study Finds

Out-of-network use 10 times higher for psychological care vs. medical care APA-funded study finds